Approval · Notice of Compliance 32671 · 2024
PEGASYS: Notice of Compliance 32671
Issued February 1, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32671
- Date
- February 1, 2024
- Company
- Pharmaand Gmbh1020 Vienna, --, Austria
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative ¿ Manufacturer Name Change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEGASYS | 02248077 | Marketed |
Medicinal ingredients
- PEGINTERFERON ALFA-2A 180 MCG per 0.5ML